Literature DB >> 26814015

Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.

Rainey E Patterson1, Srilaxmi Kalavalapalli2, Caroline M Williams3, Manisha Nautiyal2, Justin T Mathew2, Janie Martinez2, Mary K Reinhard4, Danielle J McDougall1, James R Rocca5, Richard A Yost6, Kenneth Cusi7, Timothy J Garrett8, Nishanth E Sunny9.   

Abstract

The hepatic tricarboxylic acid (TCA) cycle is central to integrating macronutrient metabolism and is closely coupled to cellular respiration, free radical generation, and inflammation. Oxidative flux through the TCA cycle is induced during hepatic insulin resistance, in mice and humans with simple steatosis, reflecting early compensatory remodeling of mitochondrial energetics. We hypothesized that progressive severity of hepatic insulin resistance and the onset of nonalcoholic steatohepatitis (NASH) would impair oxidative flux through the hepatic TCA cycle. Mice (C57/BL6) were fed a high-trans-fat high-fructose diet (TFD) for 8 wk to induce simple steatosis and NASH by 24 wk. In vivo fasting hepatic mitochondrial fluxes were determined by(13)C-nuclear magnetic resonance (NMR)-based isotopomer analysis. Hepatic metabolic intermediates were quantified using mass spectrometry-based targeted metabolomics. Hepatic triglyceride accumulation and insulin resistance preceded alterations in mitochondrial metabolism, since TCA cycle fluxes remained normal during simple steatosis. However, mice with NASH had a twofold induction (P< 0.05) of mitochondrial fluxes (μmol/min) through the TCA cycle (2.6 ± 0.5 vs. 5.4 ± 0.6), anaplerosis (9.1 ± 1.2 vs. 16.9 ± 2.2), and pyruvate cycling (4.9 ± 1.0 vs. 11.1 ± 1.9) compared with their age-matched controls. Induction of the TCA cycle activity during NASH was concurrent with blunted ketogenesis and accumulation of hepatic diacylglycerols (DAGs), ceramides (Cer), and long-chain acylcarnitines, suggesting inefficient oxidation and disposal of excess free fatty acids (FFA). Sustained induction of mitochondrial TCA cycle failed to prevent accretion of "lipotoxic" metabolites in the liver and could hasten inflammation and the metabolic transition to NASH.

Entities:  

Keywords:  hepatic insulin resistance; mitochondria; nonalcoholic steatohepatitis; steatosis

Mesh:

Substances:

Year:  2016        PMID: 26814015      PMCID: PMC4824140          DOI: 10.1152/ajpendo.00492.2015

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  42 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  pcaMethods--a bioconductor package providing PCA methods for incomplete data.

Authors:  Wolfram Stacklies; Henning Redestig; Matthias Scholz; Dirk Walther; Joachim Selbig
Journal:  Bioinformatics       Date:  2007-03-07       Impact factor: 6.937

3.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

4.  Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting.

Authors:  Shawn C Burgess; F Mark H Jeffrey; Charles Storey; Angela Milde; Natasha Hausler; Matthew E Merritt; Hindrik Mulder; Cecilia Holm; A Dean Sherry; Craig R Malloy
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-29       Impact factor: 4.310

5.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

Review 7.  Ceramides in insulin resistance and lipotoxicity.

Authors:  Scott A Summers
Journal:  Prog Lipid Res       Date:  2005-12-19       Impact factor: 16.195

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

9.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.

Authors:  Dongyan Zhang; Zhen-Xiang Liu; Cheol Soo Choi; Liqun Tian; Richard Kibbey; Jianying Dong; Gary W Cline; Philip A Wood; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

View more
  55 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

Review 2.  Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease.

Authors:  Lindsey S Treviño; Tiffany A Katz
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

3.  Heat shock protein 72 regulates hepatic lipid accumulation.

Authors:  Ashley E Archer; Robert S Rogers; Alex T Von Schulze; Joshua L Wheatley; E Matthew Morris; Colin S McCoin; John P Thyfault; Paige C Geiger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-20       Impact factor: 3.619

4.  Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice.

Authors:  Su-Kyung Shin; Hyun-Woo Cho; Seung-Eun Song; Jae-Hoon Bae; Seung-Soon Im; Inha Hwang; Hunjoo Ha; Dae-Kyu Song
Journal:  Pflugers Arch       Date:  2019-01-07       Impact factor: 3.657

5.  Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.

Authors:  Muhammed S Muyyarikkandy; Marc McLeod; Meghan Maguire; Rohit Mahar; Nathan Kattapuram; Christine Zhang; Chaitra Surugihalli; Vaishna Muralidaran; Kruthi Vavilikolanu; Clayton E Mathews; Matthew E Merritt; Nishanth E Sunny
Journal:  FASEB J       Date:  2020-09-12       Impact factor: 5.191

Review 6.  Non-alcoholic fatty liver disease: Insights from sphingolipidomics.

Authors:  David J Montefusco; Jeremy C Allegood; Sarah Spiegel; L Ashley Cowart
Journal:  Biochem Biophys Res Commun       Date:  2018-05-21       Impact factor: 3.575

7.  Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Shanshan Jin; Suwen Jiang; Airong Hu
Journal:  Sleep Breath       Date:  2018-01-15       Impact factor: 2.816

8.  Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.

Authors:  Kang-Yu Peng; Matthew J Watt; Sander Rensen; Jan Willem Greve; Kevin Huynh; Kaushala S Jayawardana; Peter J Meikle; Ruth C R Meex
Journal:  J Lipid Res       Date:  2018-07-24       Impact factor: 5.922

9.  Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice.

Authors:  Clinton M Hasenour; Arion J Kennedy; Tomasz Bednarski; Irina A Trenary; Brandon J Eudy; Robin P da Silva; Kelli L Boyd; Jamey D Young
Journal:  J Lipid Res       Date:  2020-02-21       Impact factor: 5.922

10.  Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.

Authors:  Srilaxmi Kalavalapalli; Fernando Bril; Jeremy P Koelmel; Kaitlyn Abdo; Joy Guingab; Paige Andrews; Wen-Yi Li; Dhanya Jose; Richard A Yost; Reginald F Frye; Timothy J Garrett; Kenneth Cusi; Nishanth E Sunny
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-04-10       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.